XBIO 8-K 2026-01-09

Xenetic Biosciences, Inc. (XBIO) 8-K dated 2026-01-09 — accession 0001683168-26-000196. This URL is the filing, not the XBIO hub.

Xenetic Biosciences, Inc. (XBIO) is a biotechnology company listed on US.

Xenetic Biosciences, Inc. filed a 8-K on 2026-01-09. Accession 0001683168-26-000196.

Cached items: 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.

Not investment advice. The XBIO SEC hub lists recent forms. The stock page is the research view.